Omeros gains $20M from Vulcan and $5M from Life Sciences Discovery Fund

Omeros Corporation, a Seattle-based clinical-stage biopharmaceutical company, announced “that it has received $20 million from Vulcan Capital (Vulcan) and a grant award for $5 million from Washington State’s Life Sciences Discovery Fund (LSDF) to support the advancement of the Company’s G protein-coupled receptor (GPCR) program. In return, Vulcan Capital and LSDF have a right to receive a percentage of net proceeds generated by the GPCR program.”

Learn more at Omeros

This entry was posted in Company_and_Client_News, Funding, Life_Sciences, Life_Sciences_Discovery_Fund, Omeros. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s